A Perspective on sigma-1 receptor research: Past and future  by Su, Tsung-Ping
ble at ScienceDirect
Journal of Pharmacological Sciences 127 (2015) 1Contents lists availaHOSTED BY
Journal of Pharmacological Sciences
journal homepage: www.elsevier .com/locate/ jphsPrefaceA Perspective on sigma-1 receptor research: Past and futureThe description of the sigma-1 receptor came about as a binding
site for a subtype of opioid receptors which was soon rectiﬁed as a
non-opioid receptor of its own. It has been 33 years after the ﬁrst
description of the sigma-1 receptor during which period the recep-
tor has been demonstrated to be a protein with many never-before
described features. The reason for this uniqueness of the sigma-1
receptor is partly due to the fact that its sequence does not
resemble that of any mammalian proteins, leading to the situation
that no pre-existing description could be followed in searching for
its potential physiological roles. It is also because of this uniqueness
of the sigma-1 receptor that opens up opportunities to search for its
functions in many physiological systems particularly as they may
relate to human diseases. It is thus a great pleasure to see that
the Journal of Pharmacological Sciences is devoting a special issue
in the beginning of year 2015 to focus on the sigma-1 receptor
research.
The sigma-1 receptor has so far been implicated in diseases
including Alzheimer’s disease, Parkinson’s disease, psycho-
stimulant addiction, cancer, myocardial hypertension, aging, cogni-
tion, depression, fronto-temporal lobar motor neuron degenera-
tion, amyotrophic lateral sclerosis, and HIV-associated neural
dementia. As sigma-1 receptors exist in immune systems, functions
of sigma-1 receptors in certain immune system have also been re-
ported in the literature. This plethora of involvement of sigma-1 re-
ceptors in so many different types of diseases raises a fundamental
question: what is the mode of action of the sigma-1 receptor that
relates this receptor to so many different diseases? This has been
a “burning” question for many researchers both inside and outside
of the ﬁeld of the sigma-1 receptor.
The discovery that the sigma-1 receptor is an endoplasmic retic-
ulum (ER) chaperone that resides mainly in the interface between
the ER and mitochondrion, referred to as the MAM (mitochon-
drion-associated ER membrane), has provided a piece of pivotal in-
formation to understanding the receptor’s function. Further, the
demonstration that sigma-1 receptors can translocate to other
areas of cells or neurons, when stimulated by its agonists such as
neurosteroids or psychostimulants, adds additional dimensions to
understanding the receptor’s mode of action and associatedhttp://dx.doi.org/10.1016/j.jphs.2014.11.001
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creativecommons.org/licenses/by-nc-nd/4.0/).physiological functions. Thus, we know now that sigma-1 receptors
function locally at the MAM but also remotely for example at the
plasma membrane. However, whether those two modes of actions
of sigma-1 receptors may relate themselves to so many different
diseases remain to be totally clariﬁed. For example, are there other
modes of action of sigma-1 receptors? Or, modes of action may
differ in different organs or tissues? Those are questions to be
answered in future investigations.
Thus, it seems that the major hurdles to understanding the
properties of sigma-1 receptors have been removed because of
the advancements of technologies and associated ﬁndings as
mentioned above. However, several fundamental questions con-
cerning the sigma-1 receptor remain to be totally clariﬁed. For
example, what is the driving force that propels the translocation
of sigma-1 receptors? What molecular mechanism(s) directs the
underpinning targeting of sigma-1 receptors to the other parts of
cell or neuron? What molecular mechanism(s) or speciﬁcity deter-
mines the targeted client protein that sigma-1 receptors will asso-
ciate with either at the MAM or at remote parts of a cell? How do
those molecular mechanisms, if fully established, relate to humans
diseases?
The major discoveries on the fundamental properties and func-
tions of the sigma-1 receptor mostly occur in the past ﬁve years af-
ter the receptor’s initial discovery in 1982. The next decade should
mark a critical and fruitful periodwhenmore important and pivotal
ﬁndings will clarify and shape further our fundamental under-
standing of this receptor which has eluded our efforts for so long
in the past.Tsung-Ping Su
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